Purchase Order 75D30120P09454
Award Date 8/25/20
Potential Completion Date 8/30/21
Potential Value $184K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award HHSD2002016M89006P was issued by the Centers for Disease Control and Prevention (CDC) to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The $139,200.00 firm fixed price purchase order is for the maintenance of laboratory equipment. Agena Bioscience has previously provided genomic testing supplies and equipment to agencies such as the CDC, Department of Veterans Affairs, and Veterans Health...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The contract, valued at $77,553.00, is for the delivery of IPLEX GOLD, PCR REAGENT AND SPECTROCHIP KIT. Agena Bioscience has previously provided similar genomic testing supplies and equipment to federal agencies like the CDC and Department of Veterans Affairs through past...
- Agena Bioscience, Inc. has been awarded a firm fixed price purchase order valued at twenty-two thousand five hundred fifty-five dollars ($22,555) by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of Agena Bioscience IPLEX Pro Genotyping Kits to the CDC facility in San Diego, California, with performance taking place between September 7-15, 2023. No subcontractors or set aside designations were indicated. The genotyping...
- This is a firm fixed-price purchase order awarded by the Pacific West Area office of the Centers for Disease Control and Prevention (CDC) to Agena Bioscience, Inc., a for-profit corporation based in San Diego, California. The $8,466.00 contract is for the delivery of IPLEX GOLD REAGENT KIT (LARGE), SPECTROCHIP RESIN KIT (10X384), PCR ACCESSORY KIT, and PCR ENZYME. The award does not have a set-aside designation, indicating open competition. Agena Bioscience is a subsidiary of Telegraph Hill...
- The U.S. government awarded a $27,947 firm fixed-price purchase order to Agena Bioscience, Inc. for specialized genomic testing supplies and equipment components. The contract, awarded on May 4, 2015, with an ultimate completion date of May 23, 2015, procures three categories of items: IPLEX Gold Reagent Kits, SpectraChip Arrays and Clean Resin Kits, and PCR accessory kits. The work is to be performed in Pullman, Washington, and no set-aside designation was used for this procurement. The funding...
- This is a $320,580.00 firm fixed price definitive contract awarded by the Department of Veterans Affairs (VA) to Agena Bioscience, Inc., a for-profit company that provides genomic testing equipment, reagents, and services to clinical laboratories and research institutions. The contract is for preventative maintenance services and has an ultimate completion date of August 31, 2019. No set-aside designation was used for this award. Through past federal contracts, Agena Bioscience has provided...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $142,275.95 firm fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer of scientific equipment and tools for biomedical research and genetic analysis. The contract is for the delivery of a Life Technology Genetic Analyzer, with a completion date of July 27, 2020. Life Technologies has previously supplied specialized products, such as reagents, instruments, and...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $205,470.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, which is not set aside, is for the provision of reagents, test kits, instruments, and testing platforms to support the CDC's clinical diagnostic programs. Cepheid, as the prime contractor, has a...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $1.2 million firm fixed price purchase order to Aegis Sciences Corporation of Nashville, Tennessee for genomic sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing under its Aegis Analytical Laboratories division. The contract runs from March 1, 2021 through April 15, 2021 to support genomic sequencing efforts at the CDC, likely related to...